$7.08
1.60% yesterday
Nasdaq, Jun 27, 10:04 pm CET
ISIN
US45780L1044
Symbol
INGN

Inogen, Inc. Stock price

$7.08
+0.46 6.95% 1M
-1.50 17.48% 6M
-2.09 22.79% YTD
-0.89 11.17% 1Y
-18.55 72.38% 3Y
-27.84 79.73% 5Y
-36.05 83.58% 10Y
-8.07 53.27% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.12 1.60%
ISIN
US45780L1044
Symbol
INGN
Sector

Key metrics

Basic
Market capitalization
$190.4m
Enterprise Value
$71.5m
Net debt
$-118.9m
Cash
$118.9m
Shares outstanding
26.9m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.56 | 0.53
EV/Sales
0.21 | 0.20
EV/FCF
negative
P/B
0.96
Financial Health
Equity Ratio
58.70%
Return on Equity
-20.64%
ROCE
-12.73%
ROIC
-21.55%
Debt/Equity
0.00
Financials (TTM | estimate)
Revenue
$340.0m | $360.8m
EBITDA
$-10.0m | $0.0
EBIT
$-30.9m
Net Income
$-27.5m | $-28.6m
Free Cash Flow
$-21.1m
Growth (TTM | estimate)
Revenue
5.74% | 7.46%
EBITDA
80.30% | 100.00%
EBIT
55.86%
Net Income
71.56% | 20.34%
Free Cash Flow
18.76%
Margin (TTM | estimate)
Gross
46.11%
EBITDA
-2.94% | 0.00%
EBIT
-9.10%
Net
-8.08% | -7.93%
Free Cash Flow
-6.21%
More
EPS
$-1.09
FCF per Share
$-0.79
Short interest
4.07%
Employees
766.00
Rev per Employee
$440.00k
Show more

Is Inogen, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Inogen, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Inogen, Inc. forecast:

7x Buy
78%
1x Hold
11%
1x Sell
11%

Analyst Opinions

9 Analysts have issued a Inogen, Inc. forecast:

Buy
78%
Hold
11%
Sell
11%

Financial data from Inogen, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
340 340
6% 6%
100%
- Direct Costs 183 183
4% 4%
54%
157 157
20% 20%
46%
- Selling and Administrative Expenses 169 169
5% 5%
50%
- Research and Development Expense 19 19
14% 14%
6%
-9.99 -9.99
80% 80%
-3%
- Depreciation and Amortization 21 21
8% 8%
6%
EBIT (Operating Income) EBIT -31 -31
56% 56%
-9%
Net Profit -27 -27
72% 72%
-8%

In millions USD.

Don't miss a Thing! We will send you all news about Inogen, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inogen, Inc. Stock News

Neutral
Business Wire
5 days ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy.
Neutral
Seeking Alpha
about 2 months ago
Inogen, Inc. (NASDAQ:INGN ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Colin Clark - Stifel Mike Matteson - Needham & Company Margaret Andrew - William Blair Operator Welcome to Inogen's First Quarter 2025 Earnings Conference Call. At this time, al...
Neutral
Business Wire
about 2 months ago
GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces First Quarter 2025 Financial Results.
More Inogen, Inc. News

Company Profile

Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.

Head office United States
CEO Kevin Smith
Employees 766
Founded 2001
Website www.inogen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today